Position in INAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,072,462
-$623,188 QoQ
Shares Held
724,637
0.0% QoQ
Ownership
7.36%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3
of 19 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $316,393,102 across 63 Biotechnology names. INAB ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | ANAB |
Anaptysbio, Inc
|
625,000 | $34,662,468 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
775,000 | $11,206,500 |
All Filings in INAB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,072,462 | 724,637 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,695,650 | 724,637 | Shares | Defined | 2026-02-17 | |
| 2025-12-22 | $1,194,189 | 770,445 | Shares | Sole | 2025-12-30 | |
| No filing history on record for this holder in this stock. | ||||||